Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The “concentration of platelets, red blood cells, and coagulation proteins” refers to laboratory-measured levels of the key cellular and soluble components responsible for blood clotting and oxygen delivery. Platelets are small anucleate cells critical for forming the initial plug at sites of vascular injury and also mediate immune functions[1][4][5]. Red blood cells (erythrocytes) transport oxygen and play mechanical and biochemical roles in promoting hemostasis through margination and direct platelet activation, including via receptor interactions and microparticle release[2][6]. Coagulation proteins (including fibrinogen, prothrombin, von Willebrand factor, and various clotting factors) circulate in plasma and enable the formation and stabilization of fibrin clots[3][4]. Measurement of these concentrations is essential in evaluating risk for bleeding and thrombosis but does not represent a single therapeutic target, receptor, enzyme, or transporter; instead, each has its own relevant molecular targets and clinical significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on concentration of platelets, red blood cells, and coagulation proteins.